Chemfab Alkalis Limited has disclosed an amended trading plan for its Chief Executive Officer, V.M. Srinivasan, providing additional clarity on the price action for his proposed share sale.

Key Details of the Amended Trading Plan

The amended plan, submitted on November 10, 2025, includes the following key points:

Background and Amendments

The original trading plan was approved on November 12, 2024, and submitted to the stock exchanges on November 13, 2024. The amendment was necessary to include price action details that were initially omitted.

Current Shareholding and Trading Conditions

Mr. Srinivasan currently holds 259,606 equity shares in Chemfab Alkalis Limited. The amended plan maintains all other terms and conditions from the original submission, including:

1. A mandatory cool-off period of 120 days.
2. No trading during specified no-trading periods.
3. A commitment not to trade for market abuse.
4. Confirmation that the insider is not in possession of any unpublished price-sensitive information.

Pricing Strategy

The price range for the proposed sale has been set between the closing price on the day before the plan's submission and up to 20% lower than that closing price. This strategy aims to provide flexibility while ensuring compliance with insider trading regulations.

Compliance and Irrevocability

The trading plan, once approved, is irrevocable under any circumstances. Mr. Srinivasan is obligated to implement the trades as outlined in the plan without deviation. This commitment aligns with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Chemfab Alkalis Limited's Compliance Officer, Bharatraj Panchal, has approved the amended trading plan on November 10, 2025. This disclosure demonstrates the company's commitment to transparency and compliance with regulatory requirements in matters of insider trading and corporate governance.

Chemfab Alkalis Limited , a prominent player in the chemical industry, has taken steps to enhance its corporate governance practices by updating its insider trading regulations. The company's Board of Directors has approved amendments to two crucial policies: the Code of Conduct to regulate, monitor, and report trading by designated persons, and the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI).

Key Changes in the Updated Code

The revised code introduces several important modifications:

1. Scope of Application: The policy now applies to all employees and connected persons who have access to unpublished price sensitive information.

2. Trading Window Restrictions: The code implements stricter controls on when designated persons can trade in the company's securities.

3. Pre-clearance Requirements: Transactions exceeding Rs. 10.00 lakhs or 10,000 shares per quarter now require pre-clearance.

4. Mandatory Disclosures: Designated persons are required to make more comprehensive disclosures about their trading activities.

5. Disciplinary Actions: The code outlines specific consequences for violations, including potential profit recovery and termination.

Implications for Stakeholders

These amendments reflect Chemfab Alkalis' commitment to maintaining high standards of corporate governance and transparency. The updated code aims to prevent insider trading and ensure fair disclosure practices, which are crucial for maintaining investor confidence and market integrity.

Compliance and Reporting

The company has appointed a Compliance Officer to oversee the implementation of these new regulations. This officer will be responsible for:

• Monitoring adherence to the rules
• Pre-clearing trades
• Maintaining records of all declarations and disclosures
• Placing reports before the Chairman of the Audit Committee on a quarterly basis

Conclusion

By strengthening its insider trading regulations, Chemfab Alkalis Limited demonstrates its dedication to ethical business practices and shareholder protection. These measures are expected to enhance the company's reputation and potentially contribute to long-term value creation for all stakeholders.

Investors and employees of Chemfab Alkalis should familiarize themselves with these new regulations to ensure compliance and avoid any unintentional violations.